Exact Mass: 400.28247400000004
Exact Mass Matches: 400.28247400000004
Found 390 metabolites which its exact mass value is equals to given mass value 400.28247400000004,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Testosterone enanthate
testosterone enanthate is used in androgen substitution to replace testosterone at levels as close to physiological levels as is possible. For some androgen-dependent functions testosterone is a pro-hormone, peripherally converted to 5alpha-dihydrotestosterone (DHT) and 17beta-estradiol (E2), of which the levels preferably should be within normal physiological ranges. Furthermore, androgens should have a good safety profile without adverse effects on the prostate, serum lipids, liver or respiratory function, and they must be convenient to use and patient-friendly, with a relative independence from medical services. Natural testosterone is viewed as the best androgen for substitution in hypogonadal men. testosterone enanthate is used to treat male hypogonadism. Male hypogonadism is one of the most common endocrinologic syndromes. The diagnosis is based on clinical signs and symptoms plus laboratory confirmation via the measurement of low morning testosterone levels on two different occasions. Serum luteinizing hormone and follicle-stimulating hormone levels distinguish between primary (hypergonadotropic) and secondary (hypogonadotropic) hypogonadism. Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism. In primary hypogonadal men the on bone mineral density (BMD) responds dose dependently to testosterone substitution, whereas in secondary hypogonadism only testosterone enanthate treatment significantly increased the BMD. In all mammalian species studied to date, testosterone has been found to be the predominant intratesticular steroid. In volunteers receiving hormonal contraception by using a combination of testosterone enanthate and levonorgestrel, there is a profound reduction of both intratesticular testosterone concentration and androgen bioactivity. High doses of testosterone enanthate can normalize hematocrit values of maintenance hemodialysis patients with replenished bone marrow iron stores. testosterone enanthate is classified as a prohibited substance by the World Anti-Doping Agency (WADA) and its use may be detected by way of the urinary testosterone/epitestosterone (T/E) ratio. (PMID: 16185098, 16467270, 15329035, 17530941, 17484401, 4028529, 12792150) [HMDB] Testosterone enanthate is used in androgen substitution to replace testosterone at levels as close to physiological levels as is possible. For some androgen-dependent functions testosterone is a pro-hormone, peripherally converted to 5alpha-dihydrotestosterone (DHT) and 17beta-estradiol (E2), of which the levels preferably should be within normal physiological ranges. Furthermore, androgens should have a good safety profile without adverse effects on the prostate, serum lipids, liver or respiratory function, and they must be convenient to use and patient-friendly, with a relative independence from medical services. Natural testosterone is viewed as the best androgen for substitution in hypogonadal men. testosterone enanthate is used to treat male hypogonadism. Male hypogonadism is one of the most common endocrinologic syndromes. The diagnosis is based on clinical signs and symptoms plus laboratory confirmation via the measurement of low morning testosterone levels on two different occasions. Serum luteinizing hormone and follicle-stimulating hormone levels distinguish between primary (hypergonadotropic) and secondary (hypogonadotropic) hypogonadism. Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism. In primary hypogonadal men the on bone mineral density (BMD) responds dose dependently to testosterone substitution, whereas in secondary hypogonadism only testosterone enanthate treatment significantly increased the BMD. In all mammalian species studied to date, testosterone has been found to be the predominant intratesticular steroid. In volunteers receiving hormonal contraception by using a combination of testosterone enanthate and levonorgestrel, there is a profound reduction of both intratesticular testosterone concentration and androgen bioactivity. High doses of testosterone enanthate can normalize hematocrit values of maintenance hemodialysis patients with replenished bone marrow iron stores. testosterone enanthate is classified as a prohibited substance by the World Anti-Doping Agency (WADA) and its use may be detected by way of the urinary testosterone/epitestosterone (T/E) ratio. (PMID: 16185098, 16467270, 15329035, 17530941, 17484401, 4028529, 12792150). D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
DG(10:0/10:0/0:0)
DG(10:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
16alpha,17-Isopropylidenedioxy-6alpha-methylprogesterone
diapolycopene
17beta-Hydroxy-5alpha-androstan-3-one cyclohexanecarboxylate
11'-Carboxy-gamma-tocotrienol
11-carboxy-r-tocotrienol is a dehydrogenation carboxylate product of 11-hydroxy-r-tocotrienol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate. Gamma-tocotrienol targets cancer cells by inhibiting Id1, a key cancer-promoting protein. Gamma-tocotrienol was shown to trigger cell apoptosis and well as anti-proliferation of cancer cells. This mechanism was also observed in separate prostate cancer and melanoma cell line studies. 11-carboxy-r-tocotrienol is a dehydrogenation carboxylate product of 11-hydroxy-r-tocotrienol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate
Colupulone
Colupulone is found in alcoholic beverages. Colupulone is a constituent of the resin of English hops
3-(Acetyloxy)-2-hydroxypropyl octadecanoate
3-(Acetyloxy)-2-hydroxypropyl octadecanoate belongs to the family of Alk(en)ylacylglycerols. These are Diradyclycerols characterized by one alk(en)yl chain and an acyl chain bound to a glycerol backbone.
DG(8:0/12:0/0:0)
DG(8:0/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/12:0)
DG(8:0/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/i-12:0/0:0)
DG(8:0/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/i-12:0)
DG(8:0/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/10:0)
DG(10:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/8:0/0:0)
DG(12:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/8:0)
DG(12:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/8:0/0:0)
DG(i-12:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/8:0)
DG(i-12:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Inecalcitol
Ajulemic acid
Cochliobolin A
Prasterone enanthate
Nocloprost
C22H37ClO4 (400.23802320000004)
(6Ar,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,9,10,10a-tetrahydrobenzo[c]chromene-9-carboxylic acid
MG(5-iso PGF2VI/0:0/0:0)
MG(5-iso PGF2VI/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/5-iso PGF2VI/0:0)
MG(0:0/5-iso PGF2VI/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
Aplysinoplide A
A sesterterpenoid isolated from the marine sponge Aplysinopsis digitata that exhibits cytotoxicity against P388 mouse leukemia cells.
23,24,25,26,27-Pentanor-3,7-dioxocucurbit-5-en-22-oic acid
13,16-Epoxy-25-hydroxy-17-cheilanthen-19,25-olide|Lintenolide C
10-O-beta-D-glucopyranosideoplopanone|oplopanone-8-O-beta-D-glucopyranoside
18-Angeloyl 鈥樎?ent-3beta,4alphaH)-15,16-Epoxy-7,13(16),14-clerodatriene-3,18-diol
1-O-isopropyl-6-O-(5,9-dimethyl-2,8-decadienoyl)-beta-D-glucopyranoside|citrusoside A
Hyrtial
A scalarane sesterterpenoid with formula C26H40O3, originally isolated from the marine sponge Hyrtios erecta.
Solidagolactone III
[(1R,3R,4R,4aS,8aR)-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2H-furan-3-yl)ethyl]-1,2,3,4a,5,6-hexahydronaphthalen-1-yl] (E)-2-methylbut-2-enoate is a natural product found in Solidago virgaurea with data available.
ent-3beta-(3-methyl-2-butenoyloxy)-15-beyeren-19-oic acid
elasclepic acid|ent-14beta-tygloyloxybeyer-15-ene-19-oic acid
(3beta,5alpha,8alpha,22E)-5,8-Epidioxy-24-norcholesta-6,22-dien-3-ol
15alpha-angeloyloxykaur-16-en-19-oic acid|15alpha-tiglinoyloxy-ent-kaurenic acid|15alpha-tiglinoyloxy-ent-kaurenoic acid|15alpha-tigloyloxy-ent-kaur-16-en-19-oic acid
24-Methyl-25-nor-12,24-dioxo-16-scalaren-22-oic acid
1(R),4beta-dihydroxy-trans-eudesm-6-ene-1-O-beta-D-glucopyranoside
3beta,11-dihydroxy-drim-8(12)-en-11-O-beta-D-glucopyranoside|xianglinmaojueside A
5-[13-(3-Furanyl)-2, 6, 10-trimethyl-3, 5-tridecadienyl]-4-hydroxy-3-methyl-2(5H)-furanone|7,8-Dihydroisopalinurin
3beta-[(beta-D-glucopyranosyl)oxy]eudesm-4(14)-en-11-ol
15alpha-senecioyloxy-ent-kaurenic acid|ent-15beta-senecioyloxy-kaur-16-en-19-oic acid
16-methoxy-1-propionyl-aspidospermidine-17,21-diol|16-methoxy-limaspermine|3-Methoxy-limaspermin
11-Cycloheptylundecanoic acid beta-oxophenethyl ester
3-hydroxy-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone|3alpha-hydroxy-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone
(ent-15beta)-Angeloyl-15-Hydroxy-16-kauren-19-oic acid|(ent-15beta)-Tigloyl-15-Hydroxy-16-kauren-19-oic acid|Angeloyl-15-Hydroxy-16-kauren-19-oic acid|Tigloyl-15-Hydroxy-16-kauren-19-oic acid
4-(1-ethoxyethyl)-5-methyl-2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzene-1,3-diol
1alpha,6beta-dihydroxy-5,10-bis-epi-eudesm-4(15)-ene-6-O-beta-D-glucopyranoside|funingensin A
(1R,2aR,6aS,7R,9aR,10aS,10bR)-7-[(1S,2Z)-1,5-dimethylhexa-2,4-dien-1-yl]-2,2a,4,6,6a,7,8,9,9a,10,10a,10b-dodecahydro-2a-methoxy-1,9a-dimethyl-1H-3-oxacyclopenta[5,6]cycloocta[1,2,3-cd]pentalen-1-ol|(5alpha,6alpha)-5-O-methylophiobolin H
7-drimen-3beta-,11-diol 3-O-beta-D-glucopyranoside
3alpha-hydroxypatchoulol 3-O-beta-D-glucopyranoside
14-[((2Z)-2-methylbut-2-enoyl)oxy]-3,4-seco-ent-kaura-4(19),16-dien-3-oic acid
3-hydroxy-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone
A tetracyclic triterpenoid found in Dysoxylum lenticellatum.
(2R*,5S*,7R*,10S*)-7-hydroperoxy-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-10-methyl-6-methylenespiro[4.5]-decane
24,25,26,27-tetranor-3-oxo-9BetaH-lanosta-7-en-23-oic acid
3beta,19-diacetoxypregna-5,20-diene|sclerosteroid B
1beta-hydroxy-3-oxo-4beta,5alpha,7alpha-H-eudesmane 11-O-alpha-L-rhamnopyranoside
2,7,11-trihydroxybisabola-1(15),9-diene 7-beta-D-fucopyranoside
(3beta,5beta,14beta,16beta,20Z)-16-acetoxy-14,21-epoxy-24-norcholan-20,22-dien-3-ol
2,7,10-trihydroxybisabola-1(15),11-diene 7-beta-D-fucopyranoside
(20R)-3beta-Hydroxy-24,25,26,27-tetranor-5alpha-cycloartan-23,21-olide|3beta-3-Hydroxy-24,25,26,27-tetranorcycloartan-23,21-olide
19-Carboxylic acid,3-(3-methyl-2-butenoyl)-(ent-3beta)-16-Kaurene-3,19-diol
(5S,6E)-5-beta-D-glucopyranosyloxy-3-hydroxy-3,7,11-trimethyldodeca-1,6,10-triene|amarantholidoside III
3beta,11-dihydroxy-drim-8(12)-en-3-O-beta-D-glucopyranoside|xianglinmaojueside B
3alpha,16beta-dihydroxy-5alpha-pregna-1,20-diene 3,16-diacetate|Di-Ac-Pregna-1,20-diene-3,16-diol
(ent-15alpha)-3-Methyl-2-butenoyl-15-Hydroxy-16-kauren-19-oic acid|15-Hydroxy-16-kauren-19-oic acid3-Methyl-2-butenoyl
1beta-(beta-D-glucopyranosyl)oxy-6alpha-hydroxyeudesman-4(15)-ene|1??-D-Glucopyranosyloxy-6??-hydroxyeudesman-4(15)-ene
1(R),4beta-dihydroxy-trans-eudesm-7-ene-1-O-beta-D-glucopyranoside|oplodiol 1-O-beta-D-glucopyranoside
5-<13-(furan-3-yl)-2,6,10-trimethyltrideca-6,8-dienyl>-4-hydroxy-3-methylfuran-2(5H)-one|5-[13-(3-Furanyl)-2, 6, 10-trimethyl-6, 8-tridecadienyl]-4-hydroxy-3-methyl-2(5H)-furanone|5-[13-(furan-3-yl)-2,6,10-trimethyltrideca-6,8-dienyl]-4-hydroxy-3-methylfuran-2(5H)-one
plakortone L
An organic heterobicyclic compound consisting of a gamma-lactone ring fused onto a substituted tetrahydrofuran ring. It is isolated from the Australian marine sponge Plakinastrella clathrata.
12beta-12-Hydroxy-24-methyl-24-oxo-16-scalaren-25-al-
18-Senecionyloxy-ent-kaurensaeure|3-Methyl-2-butenoyl-ent-18-Hydroxy-16-kauren-19-oic acid
3alpha-hydroxy-18-angeloyloxy-13-furyl-ent-labda-8(17)-ene
3alpha-angeloyloxy-15,16-epoxycleistanth-12-en-11-one
11,14-dihydroxy-drim-8(12)-en-11-O-beta-D-glucopyranoside|xianglinmaojueside C
Colupulone
Colupulone is a beta-bitter acid in which the acyl group is specified as isobutanoyl. It is a conjugate acid of a colupulone(1-). Colupulone is a natural product found in Humulus lupulus with data available. A beta-bitter acid in which the acyl group is specified as isobutanoyl.
phenyl-acetic acid 9-hydroxymethyl-7-(6-oxo-piperidin-2-yl)-octahydro-quinolizin-2-yl ester
Solidagolactone II
Elongatolide C is a natural product found in Solidago virgaurea with data available.
2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid
2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based on: CCMSLIB00000846078]
2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based: Match]
Ala Ile Val Val
Ala Leu Val Val
Ala Val Ile Val
Ala Val Leu Val
Ala Val Val Ile
Ala Val Val Leu
Gly Ile Ile Val
Gly Ile Leu Val
Gly Ile Val Ile
Gly Ile Val Leu
Gly Leu Ile Val
Gly Leu Leu Val
Gly Leu Val Ile
Gly Leu Val Leu
Gly Val Ile Ile
Gly Val Ile Leu
Gly Val Leu Ile
Gly Val Leu Leu
Ile Ala Val Val
Ile Gly Ile Val
Ile Gly Leu Val
Ile Gly Val Ile
Ile Gly Val Leu
Ile Ile Gly Val
Ile Ile Val Gly
Ile Leu Gly Val
Ile Leu Val Gly
Ile Val Ala Val
Ile Val Gly Ile
Ile Val Gly Leu
Ile Val Ile Gly
Ile Val Leu Gly
Ile Val Val Ala
Leu Ala Val Val
Leu Gly Ile Val
Leu Gly Leu Val
Leu Gly Val Ile
Leu Gly Val Leu
Leu Ile Gly Val
Leu Ile Val Gly
Leu Leu Gly Val
Leu Leu Val Gly
Leu Val Ala Val
Leu Val Gly Ile
Leu Val Gly Leu
Leu Val Ile Gly
Leu Val Leu Gly
Leu Val Val Ala
Val Ala Ile Val
Val Ala Leu Val
Val Ala Val Ile
Val Ala Val Leu
Val Gly Ile Ile
Val Gly Ile Leu
Val Gly Leu Ile
Val Gly Leu Leu
Val Ile Ala Val
Val Ile Gly Ile
Val Ile Gly Leu
Val Ile Ile Gly
Val Ile Leu Gly
Val Ile Val Ala
Val Leu Ala Val
Val Leu Gly Ile
Val Leu Gly Leu
Val Leu Ile Gly
Val Leu Leu Gly
Val Leu Val Ala
Val Val Ala Ile
Val Val Ala Leu
Val Val Ile Ala
Val Val Leu Ala
(5Z,7E,17E)-(1S,3R)-21-nor-9,10-seco-5,7,10(19),17-cholestatetraene-1,3,25-triol
(5Z,7E,17Z)-(1S,3R)-21-nor-9,10-seco-5,7,10(19),17-cholestatetraene-1,3,25-triol
19-Nor-14,20-bisepi-23-yne-1,25 dihydroxyvitamin D3
19-Nor-14-epi-23-yne-1,25 dihydroxyvitamin D3
DHEA ENANTHATE
ascr#27
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,15R)-15-hydroxyhexadec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#27
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-16-hydroxyhexadec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
ST 26:3;O3
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
Inecalcitol
1,7-bis-(tert-Butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane
C20H40N4O4 (400.30494000000004)
17-(1-methoxycyclohexyl)oxy-10,13-dimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
2,2,2,2-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetamide
C16H32N8O4 (400.25463920000004)
tert-butyl 4-(2-oxo-3,3-dipropylindol-1-yl)piperidine-1-carboxylate
Lenabasum
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D063385 - Cannabinoid Receptor Modulators D018377 - Neurotransmitter Agents > D063385 - Cannabinoid Receptor Modulators > D063386 - Cannabinoid Receptor Agonists C308 - Immunotherapeutic Agent
1,3-Propanediyl-bis(tripropylphosphonium) difluoride solution
C21H48F2P2 (400.3199131999999)
3-Hydroxy-2,2-bis(hydroxymethyl)propyl 9-octadecenoate
(2E)-16-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]hexadec-2-enoic acid
(2E,15R)-15-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]hexadec-2-enoic acid
(17E)-1alpha,25-dihydroxy-17,20-didehydro-21-norvitamin D3/(17E)-1alpha,25-dihydroxy-17,20-didehydro-21-norcholecalciferol
(1R,2S,3S,3S,4R,7S,8E,11R)-4-hydroxy-1,3,4-trimethyl-5-(2-methylprop-1-enyl)-6-oxospiro[oxolane-2,12-tricyclo[9.3.0.03,7]tetradec-8-ene]-8-carbaldehyde
(6Ar,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,9,10,10a-tetrahydrobenzo[c]chromene-9-carboxylic acid
[3-carboxy-2-[(Z)-13-carboxytridec-5-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-13-carboxytridec-7-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-13-carboxytridec-2-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-13-carboxytridec-4-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-13-carboxytridec-5-enoyl]oxypropyl]-trimethylazanium
Rapivab
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AH - Neuraminidase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D004791 - Enzyme Inhibitors
Amantadine sulfate
C20H36N2O4S (400.23956560000005)
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent C93038 - Cation Channel Blocker
(15S)-15alpha-(3-Methyl-2-butenoyloxy)kaur-16-en-18-oic acid
2-[(1E,5E,7E,9R,10R,11E)-10-hydroxy-3,7,9,11-tetramethyltrideca-1,5,7,11-tetraenyl]-6-methoxy-3,5-dimethylpyran-4-one
2,4-dioxo-3-pentyl-N-[3-(1-piperidinyl)propyl]-1H-quinazoline-7-carboxamide
C22H32N4O3 (400.24742819999994)
rel-(2R,5S,7R,10S)-7-Hydroperoxy-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-10-methyl-6-methylenespiro[4.5]-decane
A natural product found in Carthamus oxyacantha.
(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoic acid
2-(dimethylamino)-1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
C22H32N4O3 (400.24742819999994)
2-(dimethylamino)-1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
C22H32N4O3 (400.24742819999994)
(3R)-farnesyl-6-hydroxy-2,3,5-trimethyl-4-oxocyclohexa-1,5-diene-1-carboxylic acid
A sesterterpenoid that is 4-oxocyclohexa-1,5-diene-1-carboxylic acid carrying three additional methyl substituents at positions 2, 3 and 5 as well as farnsyl and hydroxy substituents at positions 3 and 6 respectively. An intermediate in the biosynthesis of terretonin.
(1-Hexanoyloxy-3-hydroxypropan-2-yl) tetradecanoate
1,1-Bis(tert-butyldimethylsilyl)-2,2-bis(trimethylsilyl)ethylene
C20H48Si4 (400.28329279999997)
(1-Hydroxy-3-propanoyloxypropan-2-yl) heptadecanoate
(1-Heptanoyloxy-3-hydroxypropan-2-yl) tridecanoate
(1-Hydroxy-3-pentanoyloxypropan-2-yl) pentadecanoate
Testosterone Enanthate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid